What is Wharton's Jelly?Wharton's Jelly is a human cell and tissue product (HCTP). As described in our clinical education material, these are structural allografts meant to supplement local cartilage defects.https://iexosomes.com/faqAre these products drugs?No. As stated in our patient education material: these products are not drugs and do not treat diseases, but they can support your body's natural healing processes.https://iexosomes.com/faqWhy do you avoid the term “stem cells”?Our clinical education material is explicit: providers should avoid unregulated terms like “stem cells” and instead focus on tissue-specific supplementation for cartilage-based defects. Using the term in clinical practice is described as scientifically inaccurate and legally risky.https://iexosomes.com/faqWhat do these products actually supply?They supply collagenic growth factors (like type I, II, and III collagen) that may help the body heal itself at a cellular level—especially when inflammation is controlled.https://iexosomes.com/faqWho validates the education?Education and clinical support are provided through the Institute of Regenerative Education, an independent third party, with protocols curated by Dr. Scott Martin.https://iexosomes.com/faqHow do patient referrals work?Patients who register are matched by ZIP code to a participating provider. Providers control whether they receive referrals, and a provider may hold a ZIP exclusively.https://iexosomes.com/faqPrescreeningProducts are obtained from healthy, carefully screened mothers at the time of normal delivery. In addition to a stringent social screening interview, all mothers undergo serology testing to ensure there is no risk for a communicable disease. No harm is brought to the mother or her newborn and parents still have the option of storing the cord blood if desired.https://iexosomes.com/sourcingProcessingRecovery of tissue is performed at the time of delivery by trained technicians in a sterile environment. All processing is done in a cGMP facility following the regulations of the FDA and the guidelines of the American Association of Tissue Banks (AATB) and the American Association of Blood Banks (AABB).https://iexosomes.com/sourcingDistributionAll products are shipped on dry ice in validated shipping containers to ensure appropriate temperature is maintained.https://iexosomes.com/sourcingWhy Wharton's Jelly?Wharton's Jelly, a connective tissue found in the umbilical cord, is primarily composed of mesenchymal stem cells and various extracellular matrix components such as collagen, chondroitin sulfate, hyaluronic acid, and sulfated proteoglycans. It boasts the highest concentration of mesenchymal stem cells per milliliter compared to other tissues rich in extracellular matrix components. Additionally, Wharton's Jelly contains clinically significant growth factors, cytokines, and extracellular vesicles. The advantages of Wharton's Jelly stem from its abundant extracellular matrix components, including collagen types I, III, and V, elastin, and fibronectin, which serve as a natural scaffold facilitating cellular adhesion. While primarily providing cushioning and structural support to the umbilical cord, Wharton's Jelly also offers a natural source of long-chain hyaluronic acid and numerous cytokines and growth factors. Notably, placental tissues, including Wharton's Jelly, are considered “immune privileged” due to their low likelihood of triggering an immune response, reducing the risk of adverse reactions.https://iexosomes.com/Connective Tissue DefectsConnective tissues hold the structures of the body together. They are made up of two different proteins, collagen, and elastin. Collagen is found in the tendons, ligaments, skin, cartilage, bone, and blood vessels. Elastin is located in the ligaments and skin. Missing, damaged, or inadequate connective tissue can lead to many symptomatic issues. This compromises the structural integrity and stability of the area. Wharton's Jelly naturally provides cushioning and structural support directly to the affected area.https://iexosomes.com/Discover the ScienceThrough extensive research and development, Wharton Jelly Shelf Stable (WJ-SS) blends the perfect fusion of science and nature. We start with umbilical cord-derived exosomes, known for their exceptional potency in Placental, Vascular Endothelial, and Transforming growth factors. This unique acellular formulation of growth factors, exclusive to WJ-SS, creates application flexibility unrivaled by other products.https://iexosomes.com/Convenience Meets PotencyWJ-SS is a shelf-stable product that requires no refrigeration. Our Lyophilization process dehydrates without denaturing the crucial peptides, proteins, and growth factors essential for collagen-based healing. This means you can safely apply WJ-SS based on patient needs.https://iexosomes.com/Transparency and TrustWe proudly disclose all ingredients, and package our product in transparent amber vials. We believe in the power of clearly seeing the purity of our products. And we guarantee that you'll be astonished by the results your clients are about to experience!https://iexosomes.com/How do we talk to patients about “Stem Cells”?When presenting human cell and tissue products (HCTPs) to patients, providers should avoid unregulated terms like “stem cells” and instead focus on tissue-specific supplementation for cartilage-based defects, explaining that these products supply collagenic growth factors (like type I, II, and III collagen) that may help the body heal itself at a cellular level—especially when inflammation is controlled. By using FDA-aligned language, discussing patient-specific regenerative capacity, and matching graft complexity to injury severity and age, clinicians can ethically and effectively guide patients through their options.https://iexosomes.com/modules/talking-to-patientsRegulatory Environment Around Stem Cells — Dispelling MythsDr. Martin delivers a critical and detailed overview of the U.S. regulatory landscape surrounding stem cells, emphasizing that using the term “stem cells” in clinical practice is scientifically inaccurate and legally risky. He explains that current compliant use involves human cell and tissue products (HCTPs) like Wharton's Jelly, which are structural allografts meant to supplement local cartilage defects—not regenerate tissue or treat systemic diseases like osteoarthritis, which would constitute unapproved drug claims.https://iexosomes.com/modules/regulatory-environmentAre Stem Cells a Scam?Dr. Martin addresses the misconception that “stem cells” are a cure-all, emphasizing that successful regenerative outcomes depend not on magical products but on proper clinical application rooted in scientific understanding—especially of collagenic differentiation. He urges providers to move beyond marketing hype, deepen their knowledge of biologic mechanisms, and practice evidence-based medicine if they want to stay competitive and deliver meaningful patient results.https://iexosomes.com/modules/are-stem-cells-a-scamThe basics behind Allogeneic ScienceDr. Martin offers a science-based explanation of how allografts—particularly Wharton's Jelly—contribute to structural support and localized tissue optimization through collagenic signaling. He encourages providers to move beyond the outdated “stem cell” terminology and focus on the well-characterized growth factor profiles found in structural tissue allografts. Dr. Martin also underscores the importance of using these materials within defined, localized applications and cautions against making non-compliant claims related to systemic effects or disease reversal.https://iexosomes.com/modules/allogeneic-scienceUnderstanding Regenerative MedicineProviders are now playing this video on an iPad for their patients before consultation to better explain the regenerative options offered, helping to warm-up the close for their treatment plan. Dr. Martin explains the benefits of regenerative therapies, particularly umbilical cord tissue-derived products like Wharton's Jelly and their role in down-regulating inflammation and supplying essential collagen for joint repair. As we age, our bodies lose the ability to produce vital collagen types, which can hinder recovery from injuries. He emphasizes that these products are not drugs and do not treat diseases, but they can support your body's natural healing processes.https://iexosomes.com/modules/understanding-regenerative-medicine